1
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Hemophilia A
1
Interventions
Cisplatin
3205
Cyclophosphamide
3200
Carboplatin
2979
Radiotherapy
2790
Paclitaxel
2720
Gemcitabine
2573
pembrolizumab
2388
Bevacizumab
2210
Docetaxel
2200
Fluorouracil
1851
Capecitabine
1834
Oxaliplatin
1742
Dexamethasone
1606
Nivolumab
1581
Doxorubicin
1503
Rituximab
1489
Magnetic Resonance Spectroscopy
1391
Etoposide
1346
Irinotecan
1248
Leucovorin
1227
Drug Therapy
1205
Cytarabine
1131
Pemetrexed
1078
fludarabine
1065
Specimen Handling
1021
Vincristine
966
Trastuzumab
946
Cetuximab
945
Prednisone
943
Lenalidomide
938
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
recombinant FVIIa
×
Clear all
NCT02622321
2021-06-24
HAVEN 1
Hoffmann-La Roche
Phase 3
Completed
113 enrolled
45 charts
1 FDA